Table. Characteristics of 15 malformed calves infected with Shamonda virus, southern Japan, December 2015-April 2016*.
Characteristic | Calf
no. |
Total | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | ||
Gestational age, d | 281 | 275 | 280 | 278 | 285 | 291 | 281 | 280 | 293 | 279 | 290 | 287 | 287 | 276 | 299 | NA |
Euthanasia | + | + | + | – | + | + | + | + | + | – | – | – | + | – | – | 9 |
Stillbirth |
– |
– |
– |
+ |
– |
– |
– |
– |
– |
+ |
+ |
+ |
– |
+ |
+ |
6 |
RT-PCR result | + | – | – | + | + | + | – | – | – | + | – | + | – | – | + | 7 |
Antibody titer |
1:8 |
1:32 |
1:32 |
1:64 |
1:2 |
1:32 |
1:32 |
1:16 |
1:8 |
1:16 |
1:4 |
1:16 |
1:16 |
1:4 |
1:64 |
NA |
Clinical finding | ||||||||||||||||
Torticollis | + | – | + | + | + | – | + | + | – | + | – | + | – | + | + | 10 |
Arthrogryposis | – | – | – | + | + | + | + | + | + | + | + | + | + | + | + | 12 |
Macroscopic finding | ||||||||||||||||
Head deformity | ||||||||||||||||
Brachygnathism | + | + | + | – | – | – | – | – | – | – | – | – | + | – | – | 4 |
Asymmetry of skull | + | – | + | – | – | – | – | – | – | – | + | + | – | – | – | 4 |
LVE | – | – | – | – | – | – | – | – | – | + | – | + | – | – | – | 2 |
Cerebellar hypoplasia | – | – | – | – | – | – | + | – | – | – | – | – | – | – | – | 1 |
Spinal curvature | + | – | + | + | + | – | + | + | – | + | + | + | – | + | + | 11 |
Muscle
discoloration |
– |
– |
– |
– |
+ |
+ |
– |
– |
+ |
+ |
+ |
– |
– |
– |
– |
5 |
Histopathologic finding | ||||||||||||||||
Cerebrum | ||||||||||||||||
Calcification of nerve cells | – | + | + | – | + | – | + | – | – | – | – | + | – | – | – | 5 |
Brainstem | ||||||||||||||||
Calcification of nerve cells | – | – | + | + | – | + | – | + | – | + | – | + | – | + | + | 8 |
Perivascular infiltration | – | + | – | – | – | + | + | + | + | + | – | – | – | – | – | 6 |
Gliosis | – | – | + | + | – | + | – | – | – | + | – | – | – | + | – | 5 |
Spinal cord | ||||||||||||||||
Decrease/disappearance of ventral horn cells | – | – | – | + | – | + | + | – | + | + | + | + | + | + | + | 10 |
Skeletal muscles | ||||||||||||||||
Fatty replacement | + | – | + | – | + | + | + | – | + | + | + | + | + | + | + | 12 |
Atrophy | + | – | + | – | + | + | + | – | + | – | + | – | – | + | + | 9 |
Myositis | + | – | + | – | + | + | + | – | + | – | + | – | – | + | + | 9 |
*LVE, lateral ventricular enlargement; NA, not applicable; RT-PCR, reverse transcription PCR; +, positive; –, negative.